Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DPER .001s UP!!
DPER .0009s GOING
DPER .0009s FALLING
DPER Heads up 30% on light volume.
DPER +30% on light volume!!
DPER +30% heads up
NP you in this if so CONGRATS!!!
VRMLQ Talk about a Late Friday BOMBSHELL
MADISON, N.J. and FREMONT, Calif., Sept. 11 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy. The test was developed by Vermillion, Inc. (OTC: VRMLQ.PK), a molecular diagnostics company, in cooperation with Quest Diagnostics (NYSE: DGX), the world's leading provider of cancer diagnostics. Quest Diagnostics, which is a long-time investor in research and development of the OVA1 technology, has exclusive rights to offer the test to the clinical reference laboratory market in the U.S. for three years.
"When combined with other clinical information, the OVA1 biomarker panel can help assess the likelihood of malignancy of an ovarian tumor before surgery and facilitate decisions about referral to a gynecologic oncologist," said Frederick R. Ueland, M.D., principal investigator of the prospective, multi-center OVA1 clinical trial. Dr. Ueland is an associate professor gynecologic oncology at the University of Kentucky's Markey Cancer Center.
The OVA1 Test is an in vitro diagnostic multivariate index (IVDMIA) test that combines the results of five immunoassays using a proprietary unique algorithm to produce a single numerical score indicating a women's likelihood of malignancy. The OVA1 Test provides a new option in the pre-operative evaluation to help physicians assess if a pelvic mass is benign or malignant in order to help determine whether to refer a woman to a gynecologic oncologist for surgery. Numerous clinical practice guidelines recommend that women with ovarian cancer be under the care of a gynecologic oncologist. However, only an estimated one third of women who undergo surgery for possible ovarian cancer are referred to these specialist surgeons for their surgery.(1)
Vermillion received the Society for Gynecologic Oncologists (SGO) Basic Science Poster Award for an abstract on the performance of its OVA1 Test presented at SGO's 38th Annual Meeting on Women's Cancer in 2007. In reviewing the test application, the FDA evaluated results of a prospective, double-blind clinical trial which included 27 demographically mixed sites representative of institutions where ovarian tumor subjects may undergo a gynecological examination.
"Surgery in the hands of a gynecologic oncologist is usually associated with more favorable patient outcomes," said Jon R. Cohen, M.D., chief medical officer and senior vice president, Quest Diagnostics. "Physicians often do not know if a woman's pelvic mass is malignant or benign until she undergoes surgery. The OVA1 Test is the first FDA-cleared blood test to help clinicians determine whether to refer a woman to a gynecologic oncologist or have a gynecologic oncologist present at the time of surgery. We believe this test will help drive more favorable patient outcomes."
"Unfortunately, advances in ovarian cancer diagnosis and treatment are few and far between. It is fitting that September, Ovarian Cancer Awareness Month, marks FDA's clearance of OVA1, a test that represents an important step forward toward improved outcomes," said Gail S. Page, executive chairperson of the board of directors of Vermillion. "Quest Diagnostics had the foresight to recognize the potential value of this novel multivariate assay and supported its development. We look forward to collaborating to bring this new diagnostic option to the many women who will benefit from specialist care."
The FDA clearance of OVA1 makes Quest Diagnostics the only diagnostic testing company to offer FDA cleared tests for ovarian cancer in the pre- and post-surgical settings. In addition to offering the OVA1 Test, Quest Diagnostics was the first laboratory company to provide a new lab test that the FDA cleared in the third quarter of 2008 as an aid for monitoring for recurrence of epithelial ovarian cancer.
The OVA1 Test will be available for physician use in the fourth quarter of this year.
IJJP .02 Here is the News
CAPITAL HEIGHTS, Md., Sept. 10 /PRNewswire-FirstCall/ -- IJJ Corp. (Pink Sheets: IJJP - News) is pleased to announce that the Company has received a purchase order from MV Transportation's District Office in Capitol Heights, Maryland for a Voice over Internet Protocol's (VoIP) unlimited calling plan.
MV Transportation, Inc. is the largest privately held and domestically owned transportation Management Company in the United States. The VoIP system will provide an on-site IP PBX Phone component with expansion ability for up to 1,000 phone extensions, over 19 administrative, and end-user features. This contract represents IJJC's first installation of this Office PBX softswitch unit, designed under the Digium Asterisk brand name.
"We evaluated lots of solutions but found IJJ Corp's VoIP system to be easy to use, robust and very cost effective," stated Paul Healey, Project Manager of MV Transportation, Inc. for Branch 113.
"We are very pleased to add an established company like MV Transportation to our growing list of VoIP customers. They have broad communication needs with over 10,000 employees and operations in a majority of states. IJJ Corp is providing them with an efficient and cost effective means of meeting their communication needs, beginning in one of their district offices," stated Clifford Pope, President and CEO of IJJ Corp.
About MV Transportation, Inc.
Based in Fairfield, California, MV is the largest private provider of Paratransit services and the largest privately owned transportation-contracting firm in the United States. The company employs more than 12,000 dedicated transit professionals and operates more than 190 Paratransit, fixed-route, shuttle and Medicaid contracts in 24 states Washington, DC and Vancouver, British Columbia.
About IJJ Corp.:
IJJ Corp. is a Diversified Technologies company focused on developing high tech solutions for the government and the private sector to provide rapid decision through information processing. The Company's technologies include: Voice, Data and Video Rapid Conferencing Solutions; Disaster Shelter Recovery Systems; Mobile Disaster Management Systems; Medical Hospital Advisor Systems; IT Management and Consulting Services; Secure Data Center Services; Network Operation Centers; and Enterprise Management Power Suites. The Company's objective is to continue to develop and integrate services and products in order to provide the most comprehensive, cutting edge, turnkey solutions to its clients.
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.
Contact:
IJJ Corp.
Investor Relations
407-389-5900
Buzz up! 0
Send
Share
Print
Share this page
*
Delicious
*
Twitter
*
Myspace
*
Digg
*
StumbleUpon
*
Facebook
Related Headlines
* IJJ Corp. Receives Purchase Order from Leading Transportation Management Company MV Transportation, Inc. - PR Newswire
* IJJ Corp. Wholly Owned Subsidiary VClouds Limited Receives Initial Purchase Order from Leading Irish Case Management Software Supplier - PR Newswire
* IJJ Corp. Completes Acquisition of Dynamic European Technology Company - PR Newswire
Top Stories
* Stock Market Less Confident After 5-day Run - Marketwatch.com
* U.S. consumer sentiment improves, inventories drop - Reuters
* AP Source: GM to restore salaried worker pay cuts - AP
* Morgan Stanley CEO to inherit bank in transition - AP
* Oil moves above $72 a barrel as dollar weakens - AP
Related Message Boards
* IJJ Corp.
Sponsored Links
*
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
*
Super Cheap Car Insurance
Get Discount Car Insurance Quotes Online – Rates from $15 / Month.
Discount-Car-Insurance-Rates.com
*
Obama Urges Homeowners to Refinance
$180,000 Refinance $939/mo. See Rates- No Credit Check Req.
SeeRefinanceRates.com
*
Buy Stocks - $4 Fee at ShareBuilder
No account or investment minimums. No inactivity fees. Start today.
www.sharebuilder.com
ADVERTISEMENT
Tech Ticker Recent Posts
* Rating Agencies "Under Siege": Einhorn Right to Be Short, Rosner Says - Aaron Task
* Ten Bubbles in the Making - Lawrence Delevingne
* "We're Not Out of the Woods Yet": Bank Rally to Stall in Q4, Rosner Says - Aaron Task
View More »
ADVERTISEMENT
Subscribe to Topics
* Top Stories
o + My Yahoo
o RSS
o Add Alert
* ijjp.pk Headlines
o + My Yahoo
o RSS
o Add Alert
Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressl
DPER .0007 R/M target~she ran fast the other day when vol hit some big buy orders just went through. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41310348
DPER .0007 got some volume coming in she moves fast
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41310348
DPER .0007 R/M candidate Volume coming in.
DPER .0007 R/M candidate Volume coming in
DPER Bid UPtick~ .0007 x .0009 Everyone should do a little digging on this one ;)
Same Here in around .053 lets hope Lazard Freres & Co comes through and helps them put the $2B on layaway. Other than the Debt the Financials aint so bad.
Getting Close to D-day for CTDB will be fun to watch
Morning Folks
LMAO...In Rainmakers defense his DD checks out clean as a whistle here. I am a buyer here.
DPER- More Nibbles coming in .001 R/M Target http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41310348
LDSR NEWS
WUHAN, China, Sept. 10 /PRNewswire-FirstCall/ - Land Star Inc. (LDSR) www.landstarcorp.com operating subsidiary, Hubei Chuguan Industry Co. Ltd., and Guangzhou North Condensation energy Technology Co., Ltd. Completed a sales and agent agreement. In accordance with the agreement, Guangzhou North Condensation Energy Technology Co., Ltd in Guangzhou will sell 200 sets of oil and gas vapor recovery processing equipment manufactured by Hubei Chuguan Industrial Co, Ltd. The VRUJ-5-type oil and gas recovery units are the pride and joy of LandStar and Hubei Chuguan Industry Co. Ltd primary workhorse. The units are industry leading edge and technologically far superior than anything else in the marketplace.
With the oil and gas recovery comprehensive and management project, together with related Accessories, the total value of contract is about 50 million RMB Chinese yuan, about 7.3 Million USD source www.xe.com
Mr Li, Congtang CEO of Chuguan said (SIC): "Although we run multiple projects now, we have enough resources to fill this order and execute this contract on time. We are lining up resources now, I am confident that it will only take couple of years to fully execute the contract and put all devices and facility in place per the contract."
DPER .0007 x .0015 R/M Candidate http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41310348
Morning Beans
DPER .0007 x .0015 R/M Candidate http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41310348
DPER .0012 little Dip before the EOD push ALL ABOARD
UPB thats the BEHL news
EXPU finally Broke .07s .10s EOW IMO
DPER~ R/M through Meuse's company
http://www.belmontpartners.net/transactions/
DPER~ Joseph Meuse has done interview on all the major business channels. Big into CHINA GROWTH
DPER~ Joseph Meuse has done interview on all the major business channels. Big into CHINA GROWTH
DPER MM falling back to .0021
DPER MM Falling back to .0021!!!
EXPU Broke the .07s looks like next stop is .10
That's how we do it BEANERS BRING THE DD
DPER .0016s WEEEEEEEEEEEEEEEEEEEEEEEE
DPER .0017s UP
DPER .0012s
DPER .0011s
DPER .001s UP